{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:49:23Z","timestamp":1792608563228,"version":"4.5.0"},"reference-count":58,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2016,5,24]],"date-time":"2016-05-24T00:00:00Z","timestamp":1464048000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0156198","type":"journal-article","created":{"date-parts":[[2016,5,24]],"date-time":"2016-05-24T13:35:26Z","timestamp":1464096926000},"page":"e0156198","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":49,"title":["Palmitoylethanolamide Modulates Inflammation-Associated Vascular Endothelial Growth Factor (VEGF) Signaling via the Akt\/mTOR Pathway in a Selective Peroxisome Proliferator-Activated Receptor Alpha (PPAR-\u03b1)-Dependent Manner"],"prefix":"10.1371","volume":"11","author":[{"given":"Giovanni","family":"Sarnelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"D\u2019Alessandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Iuvone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Capoccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Gigli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcella","family":"Pesce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Seguella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Nobile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Aprea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Maione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni Domenico","family":"de Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Cuomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Steardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,5,24]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/ar575","article-title":"Angiogenesis in rheumatoid arthritis","volume":"4","author":"EM Paleolog","year":"2002","journal-title":"Arthritis Res"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/path.2518","article-title":"Novel concepts in atherogenesis: angiogenesis and hypoxia in atherosclerosis","volume":"218","author":"JC Sluimer","year":"2009","journal-title":"J Pathol"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2174\/157339909787314149","article-title":"Diabetic retinopathy and angiogenesis","volume":"5","author":"TN Crawford","year":"2009","journal-title":"Curr Diabetes Rev. United Arab Emirates"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35025220","article-title":"Angiogenesis in cancer and other diseases","volume":"407","author":"P Carmeliet","year":"2000","journal-title":"Nature"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrrheum.2015.164","article-title":"Targeting of proangiogenic signalling pathways in chronic inflammation","volume":"12","author":"SW Tas","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1096\/fasebj.11.6.9194526","article-title":"The codependence inflammation of angiogenesis and chronic","volume":"11","author":"JR Jackson","year":"1997","journal-title":"FASEB J"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"970890","DOI":"10.1155\/2015\/970890","article-title":"Angiogenesis in Inflammatory Bowel Disease","volume":"2015","author":"C Alkim","year":"2015","journal-title":"Int J Inflam"},{"issue":"7","key":"ref8","first-page":"2060","article-title":"Angiogenesis as a novel component of inflammatory bowel disease pathogenesis","volume":"130","author":"S Danese","year":"2006","journal-title":"Gastroenterology. AGA Institute American Gastroenterological Association"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrm1911","article-title":"VEGF receptor signalling\u2014in control of vascular function","volume":"7","author":"A-K Olsson","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1046\/j.1523-1755.1999.00610.x","article-title":"Role of vascular endothelial growth factor in the regulation of angiogenesis","volume":"56","author":"N Ferrara","year":"1999","journal-title":"Kidney Int"},{"issue":"7","key":"ref11","doi-asserted-by":"crossref","first-page":"e102975","DOI":"10.1371\/journal.pone.0102975","article-title":"Allyl isothiocyanate ameliorates angiogenesis and inflammation in dextran sulfate sodium-induced acute colitis","volume":"9","author":"M Davaatseren","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.foodchem.2012.07.096","article-title":"SB365, Pulsatilla saponin D suppresses the proliferation of human colon cancer cells and induces apoptosis by modulating the AKT\/mTOR signalling pathway","volume":"136","author":"MK Son","year":"2013","journal-title":"Food Chem. Elsevier Ltd"},{"issue":"51","key":"ref13","first-page":"1","article-title":"PI3K\/AKT\/mTOR Pathway in Angiogenesis","volume":"4","author":"J Karar","year":"2011","journal-title":"Front Mol Neurosci"},{"issue":"2","key":"ref14","first-page":"119","article-title":"Hypoxia-inducible factor 1: regulation, involvement in carcinogenesis and target for anticancer therapy","volume":"92","author":"E Clottes","year":"2005","journal-title":"Bull Cancer"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4161\/org.25970","article-title":"Hypoxia-based strategies for angiogenic induction: the dawn of a new era for ischemia therapy and tissue regeneration","volume":"9","author":"E Hadjipanayi","year":"2013","journal-title":"Organogenesis"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1124\/mol.104.006353","article-title":"The Nuclear Receptor Peroxisome Proliferator-Activated Receptor-alpha Mediates the Anti-Inflammatory Actions of Palmitoylethanolamide","volume":"67","author":"J Lo Verme","year":"2005","journal-title":"Mol Pharmacol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/sj.bjp.0704466","article-title":"Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat","volume":"135","author":"S Conti","year":"2002","journal-title":"Br J Pharmacol"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/sj.bjp.0704900","article-title":"Therapeutic effect of the endogenous fatty acid amide, palmitoylethanolamide, in rat acute inflammation: inhibition of nitric oxide and cyclo-oxygenase systems","volume":"137","author":"B Costa","year":"2002","journal-title":"Br J Pharmacol"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0014-2999(00)00437-4","article-title":"Inhibition of nitric oxide production in RAW264.7 macrophages by cannabinoids and palmitoylethanolamide","volume":"401","author":"R a. Ross","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0304-3959(01)00419-5","article-title":"Attenuation of nerve growth factor-induced visceral hyperalgesia via cannabinoid CB 1 and CB 2 -like receptors","volume":"97","author":"WP Farquhar-smith","year":"2002","journal-title":"Pain"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.phrs.2009.11.005","article-title":"Levels of endocannabinoids and palmitoylethanolamide and their pharmacological manipulation in chronic granulomatous inflammation in rats","volume":"61","author":"D De Filippis","year":"2010","journal-title":"Pharmacol Res. Elsevier Ltd"},{"issue":"7","key":"ref22","doi-asserted-by":"crossref","first-page":"828","DOI":"10.2174\/1871527314666150317224155","article-title":"Palmitoylethanolamide Regulates Production of Pro-Angiogenic Mediators in a Model of beta Amyloid-Induced Astrogliosis In Vitro","volume":"14","author":"M Cipriano","year":"2015","journal-title":"CNS Neurol Disord Drug Targets. United Arab Emirates"},{"key":"ref23","article-title":"Antiproliferative and antiangiogenic effects of palmitoylethanolamide in Caco-2 human colon cancer cell involve a selective PPAR-alpha dependent inhibition of Akt\/mTOR pathway","author":"G Sarnelli","year":"2016","journal-title":"Phytotherapy Research"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/sj.bjp.0704339","article-title":"Inhibitory effect of palmitoylethanolamide on gastrointestinal motility in mice","volume":"134","author":"R Capasso","year":"2001","journal-title":"Br J Pharmacol"},{"issue":"3","key":"ref25","first-page":"541","article-title":"The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB(1), TRPV1 and PPARgamma receptors and neurotrophic factors","volume":"139","author":"B Costa","year":"2008","journal-title":"Pain. International Association for the Study of Pain"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"14966","DOI":"10.1073\/pnas.1212887109","article-title":"Fatty acid amide hydrolase ablation promotes ectopic lipid storage and insulin resistance due to centrally mediated hypothyroidism","volume":"109","author":"WH Brown","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"ref27","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1136\/gutjnl-2013-305005","article-title":"Palmitoylethanolamide improves colon inflammation through an enteric glia\/toll like receptor 4-dependent PPAR-\u03b1 activation","volume":"63","author":"G Esposito","year":"2014","journal-title":"Gut"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF02348663","article-title":"Colonic mucosal hemodynamics and tissue oxygenation in patients with ulcerative colitis: investigation by organ reflectance spectrophotometry","volume":"30","author":"M Tsujii","year":"1995","journal-title":"Gastroenterol"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1440-1746.1995.tb01068.x","article-title":"Colonic mucosal antioxidant enzymes and lipid peroxide levels in normal subjects and patients with ulcerative colitis","volume":"10","author":"L Bhaskar","year":"1995","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"ref30","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.suc.2015.08.004","article-title":"Medical Therapy for Inflammatory Bowel Disease","volume":"95","author":"P Grevenitis","year":"2015","journal-title":"Surg Clin North Am"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2147\/CEG.S58152","article-title":"Pharmacologic therapy for inflammatory bowel disease refractory to steroids","volume":"8","author":"MP Mart\u00ednez-Montiel","year":"2015","journal-title":"Clin Exp Gastroenterol"},{"issue":"6","key":"ref32","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.biopha.2014.07.006","article-title":"The PI3K\/Akt pathway in colitis associated colon cancer and its chemoprevention with celecoxib, a Cox-2 selective inhibitor","volume":"68","author":"S Setia","year":"2014","journal-title":"Biomed Pharmacother. Elsevier Masson SAS"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1196\/annals.1326.003","article-title":"The intestinal microvasculature as a therapeutic target in inflammatory bowel disease","volume":"1072","author":"O a Hatoum","year":"2006","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"ref34","first-page":"2014","article-title":"Differential angiogenic regulation of experimental colitis","volume":"169","author":"JH Chidlow","year":"2006","journal-title":"Am J Pathol [Internet]. American Society for Investigative Pathology"},{"issue":"9","key":"ref35","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1097\/01.mib.0000235095.01608.10","article-title":"The role of vascular endothelial growth factor (VEGF) in inflammatory bowel disease","volume":"12","author":"M Ferrante","year":"2006","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"ref36","doi-asserted-by":"crossref","first-page":"G648","DOI":"10.1152\/ajpgi.00466.2005","article-title":"VEGF-A stimulation of leukocyte adhesion to colonic microvascular endothelium: implications for inflammatory bowel disease","volume":"290","author":"S Goebel","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"2","key":"ref37","first-page":"585","article-title":"VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis","volume":"136","author":"F Scaldaferri","year":"2009","journal-title":"Gastroenterology. AGA Institute American Gastroenterological Association"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00109-007-0188-z","article-title":"Local administration of WIN 55,212\u20132 reduces chronic granuloma-associated angiogenesis in rat by inhibiting NF-kappa B activation","volume":"85","author":"D De Filippis","year":"2007","journal-title":"J Mol Med"},{"issue":"3","key":"ref39","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ccr.2005.08.008","article-title":"The Akt-mTOR tango and its relevance to cancer","volume":"8","author":"N Hay","year":"2005","journal-title":"Cancer Cell"},{"issue":"8","key":"ref40","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/01.cad.0000173476.67239.3b","article-title":"PI3K\/Akt\/mTOR pathway as a target for cancer therapy","volume":"16","author":"D Morgensztern","year":"2005","journal-title":"Anticancer Drugs"},{"issue":"7092","key":"ref41","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nature04869","article-title":"Ras, PI(3)K and mTOR signalling controls tumour cell growth","volume":"441","author":"RJ Shaw","year":"2006","journal-title":"Nature"},{"issue":"3","key":"ref42","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/jcp.21537","article-title":"Induction of HIF-1alpha expression by intermittent hypoxia: involvement of NADPH oxidase, Ca2+ signaling, prolyl hydroxylases, and mTOR","volume":"217","author":"G Yuan","year":"2008","journal-title":"J Cell Physiol [Internet]"},{"issue":"12","key":"ref43","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1128\/MCB.21.12.3995-4004.2001","article-title":"HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression","volume":"21","author":"E Laughner","year":"2001","journal-title":"Mol Cell Biol"},{"issue":"6","key":"ref44","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1053\/j.gastro.2011.01.056","article-title":"Hypoxia and metabolic factors that influence IBD pathogenesis","volume":"140","author":"LE Glover","year":"2011","journal-title":"Gastroenterology"},{"issue":"3","key":"ref45","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/CAD.0b013e328011e67d","article-title":"Peroxisome proliferator-activated receptor gamma: a novel target for cancer therapeutics?","volume":"18","author":"S Han","year":"2007","journal-title":"Anticancer Drugs"},{"issue":"9","key":"ref46","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1136\/gut.2006.093484","article-title":"PPARgamma as a new therapeutic target in inflammatory bowel diseases","volume":"55","author":"L Dubuquoy","year":"2006","journal-title":"Gut"},{"issue":"4","key":"ref47","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.bbrc.2011.03.086","article-title":"The inhibition of MAPK potentiates the anti-angiogenic efficacy of mTOR inhibitors","volume":"407","author":"A Dormond-Meuwly","year":"2011","journal-title":"Biochem Biophys Res Commun. Elsevier Inc"},{"issue":"12","key":"ref48","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1111\/j.1582-4934.2011.01267.x","article-title":"Palmitoylethanolamide counteracts reactive astrogliosis induced by \u03b2-amyloid peptide","volume":"15","author":"C Scuderi","year":"2011","journal-title":"J Cell Mol Med [Internet]"},{"issue":"1","key":"ref49","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/jcp.21924","article-title":"p38 MAPK activity is stimulated by vascular endothelial growth factor receptor 2 activation and is essential for shear stress-induced angiogenesis","volume":"222","author":"E Gee","year":"2010","journal-title":"J Cell Physiol"},{"issue":"5\u20136","key":"ref50","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/sj.cr.7290133","article-title":"The role of nitric oxide in cancer","volume":"12","author":"W Xu","year":"2002","journal-title":"Cell Res"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.prostaglandins.2014.10.002","article-title":"The role of PGE2 in intestinal inflammation and tumorigenesis","volume":"116\u2013117","author":"DC Montrose","year":"2015","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"4","key":"ref52","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1046\/j.1472-8206.2002.00094.x","article-title":"Effect on cancer cell proliferation of palmitoylethanolamide, a fatty acid amide interacting with both the cannabinoid and vanilloid signalling systems","volume":"16","author":"L De Petrocellis","year":"2002","journal-title":"Fundam Clin Pharmacol"},{"issue":"Pt 1","key":"ref53","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1042\/bj3580249","article-title":"Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells","volume":"358","author":"V Di Marzo","year":"2001","journal-title":"Biochem J"},{"issue":"6","key":"ref54","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1007\/s10620-009-0942-x","article-title":"Mesalamine protects against colorectal cancer in inflammatory bowel disease","volume":"55","author":"J Tang","year":"2010","journal-title":"Digestive and Liver disease"},{"key":"ref55","article-title":"Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis","author":"DT Rubin","journal-title":"Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis"},{"issue":"4","key":"ref56","first-page":"647","article-title":"Monitoring for drug side-effects in inflammatory bowel disease","volume":"66","author":"RN Cunliffe","year":"2002","journal-title":"APT"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"11","DOI":"10.36076\/ppj\/2016.19.11","article-title":"Palmitoylethanolamide, a Special Food for Medical Purposes, in the Treatment of Chronic Pain: A Pooled Data Meta-analysis","volume":"19","author":"A Paladini","year":"2016","journal-title":"Pain Physician"},{"issue":"2","key":"ref58","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s13311-016-0420-z","article-title":"Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-\u03b21a and Circulating Proinflammatory Cytokines in Relapsing-Remitting Multiple Sclerosis","volume":"13","author":"NS Orefice","year":"2016","journal-title":"Neurotherapeutics"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0156198","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T03:47:09Z","timestamp":1656560829000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0156198"}},"subtitle":[],"editor":[{"given":"Sujit","family":"Basu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,5,24]]},"references-count":58,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,5,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0156198","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,24]]}}}